Tessa Therapeutics   Report issue

For profit Phase 2 Phase 3
Founded: Singapore Singapore (2001)

Organization Overview

First Clinical Trial
2014
NCT02578641
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Tessa Therapeutics